Baird analyst Michael Halloran raised the firm’s price target on Xylem to $170 from $155 and keeps an Outperform rating on the shares. The firm said they posted a solid Q2 with its outlook unchanged. The firm moved its estimates higher and said Xylem remains a Top Idea.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XYL: